Board Member Announcement (June 2020)

cliexa is pleased to announce Jennifer Bae and Keith Pinter joining cliexa Board of Directors as new board members.

Jennifer Bae is the Managing Director of Innovation for the American College of Cardiology and built the infrastructure for ACC’s Innovation Program from the ground up.  Prior to the ACC, Jennifer worked in global health and pandemic preparedness, including at the Centers for Disease Control and Prevention and the Department of State, where she led Biosecurity Engagement Programs in South and Southeast Asia and served as the Deputy Chief of Bio-engagement globally.  She represented the US Government in a Delegation to the United Nations and crafted pandemic preparedness policies with the interagency.  Prior to her government service, she led best practice research directed at solving strategic and operational issues for the Advisory Board Company.  Jennifer holds a Master’s in Health Services Administration from the University of Michigan School of Public Health.  She speaks Mandarin Chinese, Bahasa (Indonesian), and Spanish.

“ACC built its innovation program around the digital transformation of health care delivery, with remote monitoring as a key aspect of that effort,” Bae said. “cliexa’s platform for collecting patient data both during and between medical office visits, with great attention to information security, supports our shared emphasis on improving patient care by collecting meaningful information and representing it in a way that is actionable to clinicians. I am honored to continue working with cliexa and the other board members to move this innovative vision forward.”

Keith Pinter most recently served as Chief Operating Officer for the $6.5B Physician Services group of the Fortune 500 Envision Healthcare.  Prior to Envision, Keith was Corporate Vice President for Health Management Associates, a Fortune 500 healthcare provider acquired by Community Health Systems in 2014. Previously, Mr. Pinter functioned as President of Lido Capital, XDrive, Epoch internet, and Ameritech. Mr. Pinter received his Presidential MBA from Pepperdine University in 2007. He currently chairs the University of Miami Data Sciences Executive Advisory Board, as well as serving on the boards of Accolite, Burst IQ, and Bold Destiny.

“I’m excited to assist the board and leadership team in unlocking the tremendous value which cliexa has purposefully and innovatively engineered with its unique platform, enabling providers to make informed decisions more effectively and having a holistic view of patient-reported data. cliexa’s unique platform with clinician-centric workflows, AI-driven predictive risk models and compliance framework has the potential to make a substantial difference for many of the specialties, especially so for those chronic diseases.”, Keith Pinter said,

“cliexa just got two of the best board members and advisor with great experience in healthcare innovation, clinical technology development, and healthcare operations. We are extremely lucky to have Jennifer’s and Keith’s wisdom to accelerate cliexa’s growth moving forward,” said Mehmet Kazgan, Founder and CEO of cliexa.

cliexa is a 2020 Colorado Companies to Watch Finalist

cliexa has been announced as a finalist for the 2020 Colorado Companies to Watch Award. We have been working diligently with medical providers, healthcare professionals, and expert technologists to improve patient care and treatment outcomes. Our platform has created notable impacts in healthcare through improved patient care, compliance, and technology use with predicting patient outcomes. As a finalist of the 2020 Colorado Companies to Watch Award, it is special to make a noticeable difference in our Colorado community.

Each year, Colorado Companies to Watch nominates Colorado-based businesses that rise to the challenge and help fuel the local economy. Since our inception in 2016, our goal is to make a difference in our community and have the ability to impact the future of healthcare.

2020 has brought a major turn of events for the local and national economies. We realize that 2020 will be a vital year for innovation and commitment in small businesses. Our team is dedicated to providing novel technologies that support the healthcare system. During this global pandemic, the cliexa team has worked to promote our Remote Patient Monitoring (RPM) and Telehealth services to healthcare systems around the nation. Our products provide a platform where healthcare providers can securely interact with their patients. It allows them to monitor patient activities and symptoms remotely to ensure continuity of care while shelter-in-place orders are active.

Innovative healthcare technology impacts more than just healthcare professionals; it affects everyone. cliexa creates solutions for patients, healthcare providers, and payors. Our team is proud to be a Finalist of the 2020 Colorado Companies to Watch Award, with a huge thank you to Bank of America for sponsoring this recognition!

In the past, cliexa has been announced by ColoradoBiz Magazine as a finalist at Prime Health Digital Challenge as well as Denver Metro Chamber 2020 Business Awards for Startup of the Year. 

The cliexa platform is now available on the Microsoft Azure Marketplace!

Microsoft Azure Marketplace provides applications for a range of purposes, including AI & machine learning, analytics, and blockchain. cliexa’s feature in the Azure Marketplace is an exciting step for our team. This promotion attests to the platform’s credibility and success over the years.

Microsoft Azure allows cliexa to reach the hands of many healthcare professionals and patients that desire better solutions. Many problems currently face the healthcare industry. Issues like physician burnout, patient to provider communication, and rejected reimbursements are all addressed with cliexa. The availability of cliexa on Azure Marketplace helps introduce an innovative solution to healthcare systems across the country.

How Does this Help cliexa and the Healthcare Industry?

Allowing healthcare professionals to search for a desirable digital platform when they are ready to adopt innovative technology is key. Azure Marketplace helps to promote the cliexa platform and make this helpful technology available to more clinicians who need to save time, money, and increase compliance and reimbursements.

Many healthcare clinics have adopted the cliexa platform and seen great success. New Health Services adopted the cliexa platform in 2019 and has seen a significant decrease in costs. They have decreased over 2.5 hours spent each day on intake documentation, billing documents, and information integration into the EMR. Over time, these hours translate into valuable cost savings for users of the cliexa platform.

 

In addition to costs, the cliexa platform integrates patient engagement right into the client’s existing EMR. The various specialty platforms allow for the communication of patient-reported outcomes to allow physicians to better treat patients suffering from chronic illness over time. In summary, the platform provides benefits for physicians, patients, and payors alike.

With the cliexa platform now available on the Microsoft Azure Marketplace, customers can now purchase and deploy the platform and reap the many benefits of utilizing this innovative software. cliexa’s platform can benefit many more healthcare clinicians and, in turn, help create better outcomes for patients.

Learn more about the cliexa platform by visiting our page on the Microsoft Azure Marketplace!

 

cliexa is excited to announce that we have been nominated by the Denver Metro Chamber of Commerce (DMCC) as one of the three finalists for Start-Up of the Year! Each year, the DMCC recognizes businesses in the Denver area for their exceptional work in providing great jobs and helping to shape the local business community.

 

Here at cliexa, we pride ourselves on our innovation and competitiveness among leading digital healthcare organizations. Being recognized by local business leaders as an integral part of Denver’s start-up community has us reeling with excitement. We are excited to attend the DMCC’s 2020 Business Awards on April 24th, and you can register here for the luncheon to come cheer us on!

 

The DMCC 2020 Business Awards finalists include:

  • Disruptor of the Year: AT&T, RK, and Teatulia Organic Teas
  • Minority or Women-owned Business of the Year: Aim High Chiropractic, Novitas Communications, and Workplace Resource
  • Small Business of the Year: Bespoke Event Group, Core Contractors, Roofing Systems, and YellowDog Denver
  • Start-Up of the Year: cliexa, Emerge Professional Services, and Urban Solution Group
  • Small Nonprofit of the Year: Heart & Hand Center, Project Helping, and WeeCycle
  • Large Nonprofit of the Year: Denver Scholarship Foundation, Habitat for Humanity of Metro Denver, and Metro Caring

We would like to thank the Denver Metro Chamber of Commerce and presenting sponsor BOK Financial for recognizing these finalists and highlighting 18 of Denver’s finest business leaders and innovators.

 

Today we welcomed representatives from DMCC, the Denver community, and executives from last year’s business awards to our office. During this visit, cliexa employees had the opportunity to show off their hard work and reflect on their successes while answering questions from the judges.

 

cliexa’s CEO & Founder, Mehmet, showing DMCC judges the innovative cliexa platform

 

Start-Up Business of the Year finalists include cliexa, Emerge Professional Services, and Urban Solution Group. Emerge Professional Services provides talent and retention solutions in their approach to staffing and raising talent levels in an organization. Urban Solution Group provides mitigation plans for oil and gas development through their collaboration with operators and communities. Learn more about the finalists for the DMCC 2020 Business Awards here.

cliexa's Patent Allowance for Evidence-Based Clinical Data Collection & Processing

Today, we are proud to announce that the United States Patent and Trademark Office has announced the issuance of U.S Patent Number 14,243,549 for cliexa’s “System and Methods for Disease Management.” This patent covers clinical data collection and processing using an “Evidence-Based Data Indexing” (EBDI) model which is the core function of cliexa’s modular digital intake and remote monitoring platform. cliexa enables clinicians to monitor patients’ disease activities and clinical outcomes based on standard and dynamic thresholds within treatment workflows. The platform is tailored by subspecialties and provides automated compliance and billing outputs through cliexa’s proprietary integration services engine.

Disease activity is collected digitally through clinically-validated assessments and stored in a discrete format. This data indexing is generated by a proprietary algorithm referencing connected device data, claims data, and medication adherence or complications. Dynamic stored procedures use a new algorithm every time to update the patient-reported outcome assessments in the database and the application server would process the new or multiple assessments to be enabled in mobile front-end to collect data differently to be able to predict risk factors for specific demographics and multiple chronic disease states. Our computing objects get smarter using a learning algorithm by not only comparing the multiple disease data but also the treatment responses from patients and dynamically changing treatments by their clinicians.

Patients are also presented this dynamic data (e.g. what status their disease at compared to millions of other patients with two or more chronic conditions) to become self-advocates of their care and included IoT data also feeds back to the storage service with smart computing objects to compare existing patient data with others already in the system to give an informed picture to the clinicians.

“We are extremely excited to start 2020 with this recognition by the U.S. Patent Office. As clinical data collection and analysis become more powerful every day for the healthcare industry, cliexa’s model leverages proprietary learning algorithms and AI infrastructure, managing multiple conditions by connecting patients to their providers more effectively,” said Mehmet Kazgan, Founder & CEO of cliexa.